Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
White matter disease: Early treatment of inflammatory demyelinating disease.
The conceptualization and development of a patient-reported neurogenic bladder symptom score.
Illuminating vitamin D effects on B-cells - the multiple sclerosis perspective.
Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis.
The Standards of Reporting of Neurological Disorders (STROND) checklist: Application to multiple sclerosis.
[Cognitive Impairment in Multiple Sclerosis].
Validation and cross-cultural adaptation of sexual dysfunction modified scale in multiple sclerosis for Brazilian population.
Influence of drugs on gap junctions in glioma cell lines and primary astrocytes in vitro.
[Analysis of clinical pathway in changing and disabling neurological diseases.]
Human neural progenitor cells in central nervous system lesions.
Dietary intake of nutrients and its correlation with fatigue in multiple sclerosis patients.
Directional migration and transcriptional analysis of oligodendrocyte precursors subjected to stimulation of electrical signal.
Oxidative stress and antioxidants in neurological diseases: is there still hope?
Predictors of recurrence following an initial episode of transverse myelitis.
How scientists fool themselves - and how they can stop.
Axonal degeneration in multiple sclerosis: defining therapeutic targets by identifying the causes of pathology.
Intensity of treadmill walking exercise on acute mood symptoms in persons with multiple sclerosis.
Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor.
Pediatric-Onset Multiple Sclerosis Disease Progression in Kuwait: A Retrospective Analysis.
Spinal cord ring enhancement in patients with neuromyelitis optica.
Does antiretroviral therapy for HIV reduce the risk of developing multiple sclerosis?
Role of T Follicular Helper cells in Multiple Sclerosis.
Interferon-Related Depression: A Primer on Mechanisms, Treatment, and Prevention of a Common Clinical Problem.
Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use.
A web-based decision support tool for prognosis simulation in multiple sclerosis.
Pages
« first
‹ previous
…
497
498
499
500
501
502
503
504
505
…
next ›
last »